Estimating the effect of medication adherence on health outcomes among patients with type 2 diabetes-an application of marginal structural models

Value in Health

Volumn 13, Issue 8, 2010, Pages 1038-1045

  Yu, Andrew P ^a,b   Yu, Yanni F ^c   Nichol, Michael B ^b  

^a ANALYSIS GROUP   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

adherence; marginal structural models; medication compliance; persistence; type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT;

ADULT; ARTICLE; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL;

EID: 78650088607     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2010.00787.x     Document Type: Article

References (23)

1. Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health 2008; 11: 44-7.
2. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW,. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 2002; 40: 794-811.
3. Becker MH, Maiman LA,. Sociobehaviorial determinants of compliance with health and medical care recommendations. Med Care 1975; 13: 10-24.
4. Morris LS, Schulz RM,. Patient compliance-an overview. J Clin Pharm Ther 1992; 17: 283-95.
5. Nichol MB, Venturini F, Sung JC,. A critical evaluation of the methodology of the literature on medication compliance. Ann Pharmacother 1999; 33: 531-40.
6. McDermott MM, Schmitt B, Wallner E,. Impact of medication nonadherence on coronary heart disease outcomes. A critical review. [see comment]. Arch Intern Med 1997; 157: 1921-9.
7. Robins ML,. Medication adherence and the transplant recipient: helping patients at each stage of change. Transplant Proc 1999; 31: 29S-30S.
8. Robins JM, Hernan MA, Brumback B,. Marginal structural models and causal inference in epidemiology. Epidemiology 2000; 11: 550-60.
9. Hernan MA, Brumback B, Robins JM,. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology 2000; 11: 561-70.
10. Robins JM,. Marginal structural models versus structural nested models as tools for causual inference. In:, Halloran E, Berry D, eds. Statistical Models in Epidemiology: The Environment and Clinical Trials. New York: Springer-Verlag, 1999.
11. Curtis LHHB, Eisenstein EL, Kramer JM, Anstrom KJ,. Using inverse probability-weighted estimators in comparative effectiveness analyses with observational databases. Med Care 2007; 45 (Suppl 2): S103-7.
12. Cook NR, Cole SR, Hennekens CH,. Use of a marginal structural model to determine the effect of aspirin on cardiovascular mortality in the physicians' health study. Am J Epidemiol 2002; 155: 1045-53.
13. Hillier TA, Pedula KL,. Complications in young adults with early-onset type 2 diabetes: losing the relative protection of youth. Diabetes Care 2003; 26: 2999-3005.
14. The Diabetes Control and Complications Trial Research Group. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. [see comment][erratum appears in Arch Ophthalmol 1998;116:1469]. Arch Ophthalmol 1998; 116: 874-86.
15. Chantelau E, Kohner EM,. Why some cases of retinopathy worsen when diabetic control improves. BMJ 1997; 315: 1105-6.
16. American Diabetes Association. Economic costs of diabetes in the U.S. in 2002. Diabetes Care 2003; 26: 917-32.
17. Claxton AJ, Cramer J, Pierce C,. A systematic review of the associations between dose regimens and medication compliance*1. Clin Ther 2001; 23: 1296-310.
18. DiMatteo MR,. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. [see comment]. Med Care 2004; 42: 200-9.
19. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352: 854-65.
20. Lutfey KE, Wishner WJ,. Beyond "compliance" is "adherence." Improving the prospect of diabetes care. Diabetes Care 1999; 22: 635-9.
21. Kyngas H, Duffy ME, Kroll T,. Conceptual analysis of compliance. J Clin Nurs 2000; 9: 5-12.
22. Roter DL, Hall JA, Merisca R, et al. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care 1998; 36: 1138-61.
23. McDonald HP, Garg AX, Haynes RB,. Interventions to enhance patient adherence to medication prescriptions: scientific review. [see comment][erratum appears in JAMA. 2003 Jun 25;289(4):3242]. JAMA 2002; 288: 2868-79.